Surmodics (SRDX) News Today $30.47 -0.01 (-0.03%) As of 01:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Surmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Commonwealth of Pennsylvania Public School Empls Retrmt SYSCommonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 165.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,000 shares of the company's stoMarch 27 at 4:06 AM | marketbeat.comFY2027 EPS Estimates for Surmodics Decreased by AnalystMarch 24 at 2:55 AM | americanbankingnews.comZacks Research Decreases Earnings Estimates for SurmodicsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities research analysts at Zacks Research reduced their FY2027 earnings per share (EPS) estimates for shares of Surmodics in a report issued on Thursday, March 20th. Zacks Research analyst D. Dey now forecasts that the company will post earnings peMarch 24 at 2:53 AM | marketbeat.comRoyce & Associates LP Trims Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Royce & Associates LP decreased its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 36.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,305 shares of the company's stock after selling 23,900 shares duringMarch 22, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Short Interest UpdateSurmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 271,300 shares, a drop of 37.0% from the February 13th total of 430,900 shares. Currently, 2.0% of the shares of the company are sold short. Based on an average daily trading volume, of 271,700 shares, the days-to-cover ratio is presently 1.0 days.March 16, 2025 | marketbeat.comLake Street Upgrades Surmodics (SRDX)March 8, 2025 | msn.comLake Street Capital Upgrades Surmodics (NASDAQ:SRDX) to "Buy"Lake Street Capital raised Surmodics from a "hold" rating to a "buy" rating and set a $43.00 price target for the company in a research report on Friday.March 8, 2025 | marketbeat.comFTC sues to block acquisition of SurmodicsMarch 7, 2025 | markets.businessinsider.comSurmodics drops after FTC files suit to block its planned sale to GTCRMarch 7, 2025 | msn.comSurmodics upgraded to Buy from Hold at Lake StreetMarch 7, 2025 | markets.businessinsider.comSurmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCRMarch 6, 2025 | businesswire.comSurmodics drops on report it will meet with regulators to try to save dealMarch 4, 2025 | msn.comShort Interest in Surmodics, Inc. (NASDAQ:SRDX) Decreases By 28.4%Surmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 430,900 shares, a decline of 28.4% from the January 31st total of 601,700 shares. Based on an average trading volume of 249,200 shares, the short-interest ratio is presently 1.7 days. Currently, 3.2% of the company's shares are short sold.March 3, 2025 | marketbeat.comFY2025 EPS Estimates for Surmodics Boosted by Zacks ResearchSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research increased their FY2025 earnings estimates for shares of Surmodics in a research report issued to clients and investors on Thursday, February 27th. Zacks Research analyst D. Dey now anticipates that the company will earn $0.1March 3, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Sold by Phocas Financial Corp.Phocas Financial Corp. lowered its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 82.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,779 shares of the company's stock after selling 72,681 shares duriFebruary 26, 2025 | marketbeat.comWhat is Zacks Research's Estimate for Surmodics Q2 Earnings?Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Zacks Research upped their Q2 2025 earnings estimates for shares of Surmodics in a research note issued on Wednesday, February 19th. Zacks Research analyst D. Dey now anticipates that the company will earn ($0.04) per share for the quarter, up from thFebruary 24, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Sold by Olympiad Research LPOlympiad Research LP lessened its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 82.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,464 shares of the company's stock after selling 40,127 shares duringFebruary 23, 2025 | marketbeat.comEquities Analysts Issue Forecasts for Surmodics Q3 EarningsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for Surmodics in a report issued on Wednesday, February 19th. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.08 per share forFebruary 22, 2025 | marketbeat.comSurmodics shareholders approve key proposals at annual meetingFebruary 11, 2025 | msn.comSurmodics announces clinical use of Pounce XL Thrombectomy SystemFebruary 4, 2025 | markets.businessinsider.comSurmodics (NASDAQ:SRDX) Now Covered by StockNews.comStockNews.com began coverage on shares of Surmodics in a report on Monday. They issued a "hold" rating on the stock.February 3, 2025 | marketbeat.comBarrington Research Lowers Earnings Estimates for SurmodicsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Barrington Research dropped their Q2 2025 EPS estimates for shares of Surmodics in a report issued on Friday, January 31st. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $0.00 per share for tFebruary 3, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Sees Large Growth in Short InterestSurmodics, Inc. (NASDAQ:SRDX - Get Free Report) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 462,800 shares, a growth of 33.0% from the December 31st total of 348,000 shares. Based on an average trading volume of 228,800 shares, the short-interest ratio is presently 2.0 days. Currently, 3.4% of the company's shares are short sold.February 2, 2025 | marketbeat.comSurModics (SRDX) Receives a Hold from Lake StreetFebruary 1, 2025 | markets.businessinsider.comHold Rating on SurModics Amid Revenue Shortfall and Acquisition UncertaintyJanuary 31, 2025 | markets.businessinsider.comZacks Research Has Positive Outlook of Surmodics Q2 EarningsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities research analysts at Zacks Research lifted their Q2 2025 EPS estimates for shares of Surmodics in a research note issued on Tuesday, January 28th. Zacks Research analyst D. Dey now expects that the company will earn ($0.05) per share for theJanuary 31, 2025 | marketbeat.comSurmodics reports Q1 EPS (4c), consensus (12c)January 31, 2025 | markets.businessinsider.comSurModics Hold Rating: Balancing Revenue Slowdown and Acquisition UncertaintyJanuary 31, 2025 | markets.businessinsider.comSurmodics Earnings Analysis: Q1 RecapJanuary 31, 2025 | benzinga.comSurmodics Reports First Quarter of Fiscal Year 2025 Financial ResultsJanuary 31, 2025 | finanznachrichten.deSurmodics (NASDAQ:SRDX) Releases Earnings Results, Beats Expectations By $0.04 EPSSurmodics (NASDAQ:SRDX - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.04. Surmodics had a negative return on equity of 3.79% and a negative net margin of 9.15%.January 30, 2025 | marketbeat.comSurmodics (NASDAQ:SRDX) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Surmodics in a report on Thursday.January 30, 2025 | marketbeat.comFY2025 EPS Estimates for Surmodics Increased by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research increased their FY2025 earnings per share estimates for Surmodics in a research note issued on Tuesday, January 28th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.17 per share for theJanuary 30, 2025 | marketbeat.comSurmodics (SRDX) to Release Earnings on ThursdaySurmodics (NASDAQ:SRDX) will be releasing earnings before the market opens on Thursday, February 6, Financial Modeling Prep reports.January 30, 2025 | marketbeat.comSurmodics falls on report about FTC review of GTCR dealJanuary 28, 2025 | msn.comSurmodics (NASDAQ:SRDX) Trading Down 5.5% - Here's What HappenedSurmodics (NASDAQ:SRDX) Trading Down 5.5% - Time to Sell?January 28, 2025 | marketbeat.comSurmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Surmodics in a research report on Sunday. They set a "hold" rating for the company.January 26, 2025 | marketbeat.comJPMorgan Chase & Co. Buys 27,960 Shares of Surmodics, Inc. (NASDAQ:SRDX)JPMorgan Chase & Co. raised its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 192.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,470 shares of the company's stock after purchasing an additional 27,96January 23, 2025 | marketbeat.comSurModics (SRDX) Gets a Hold from Lake StreetJanuary 16, 2025 | markets.businessinsider.comSurmodics drops after report on FTC's view on planned sale to GTCRJanuary 13, 2025 | msn.comSurmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on Surmodics in a research note on Friday. They issued a "hold" rating on the stock.January 10, 2025 | marketbeat.comPrincipal Financial Group Inc. Invests $1.19 Million in Surmodics, Inc. (NASDAQ:SRDX)Principal Financial Group Inc. acquired a new stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 30,696 shares of the company's stock, valued at approximateJanuary 5, 2025 | marketbeat.comSurmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.comStockNews.com assumed coverage on Surmodics in a report on Thursday. They issued a "hold" rating for the company.January 2, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by State Street CorpState Street Corp increased its stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 19.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 374,068 shares of the company's stock after purchasing an additionalDecember 25, 2024 | marketbeat.comStockNews.com Initiates Coverage on Surmodics (NASDAQ:SRDX)StockNews.com assumed coverage on Surmodics in a research note on Tuesday. They set a "hold" rating for the company.December 17, 2024 | marketbeat.comOddo BHF Asset Management Sas Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Oddo BHF Asset Management Sas acquired a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 170,000 shares of the company's stock, valued at approximately $6,593,000. Oddo BHF AssetDecember 13, 2024 | marketbeat.comDisciplined Growth Investors Inc. MN Sells 303,690 Shares of Surmodics, Inc. (NASDAQ:SRDX)Disciplined Growth Investors Inc. MN cut its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 52.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 276,876 shares of the company's stock afDecember 10, 2024 | marketbeat.comWhy Is SurModics (SRDX) Up 4% Since Last Earnings Report?December 6, 2024 | msn.comMurchinson Ltd. Acquires Shares of 55,000 Surmodics, Inc. (NASDAQ:SRDX)Murchinson Ltd. bought a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 55,000 shares of the company's stock, valueDecember 4, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.comStockNews.com assumed coverage on Surmodics in a research note on Sunday. They issued a "hold" rating for the company.December 1, 2024 | marketbeat.com Remove Ads Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address SRDX Media Mentions By Week SRDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRDX News Sentiment▼0.300.82▲Average Medical News Sentiment SRDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRDX Articles This Week▼82▲SRDX Articles Average Week Remove Ads Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AtriCure News Today Alphatec News Today Orthofix Medical News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Boston Scientific News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRDX) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRDX Stock Free SRDX Stock Alerts